North America Oligonucleotide Synthesis Market worth $11.34 billion by 2030
The report "North America Oligonucleotide Synthesis Market by Product [(Drugs (ASO, siRNA), Synthesized Oligos (Product (Primers, Probes)), Type (Custom, Predesigned), Reagents, Equipment), Application (Therapeutic, Research, Diagnostics)] - Forecast to 2030", is projected to grow from USD 4.77 billion in 2025 and to reach USD 11.34 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 18.9% during the forecast period.
Browse 150 market data Tables and 30 Figures spread through 200 Pages and in-depth TOC on "North America Oligonucleotide Synthesis Market by Product [(Drugs (ASO, siRNA), Synthesized Oligos (Product (Primers, Probes)), Type (Custom, Predesigned), Reagents, Equipment), Application (Therapeutic, Research, Diagnostics)] - Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/north-america-oligonucleotide-synthesis-market-69463313.html
Several factors are driving the North America oligonucleotide synthesis market. A major driver is the strong base of pharma and biotech companies advancing ASO, siRNA, and gene-editing programs. These are keeping the demand high for GMP-grade, high-purity oligos. This sustains steady spending on core synthesis chemistries, purification, and advanced analytical testing. Additionally, hospital networks and specialty clinics are becoming major consumption points for approved oligo-based drugs. This is increasing the requirement for reliable commercial supply and lot consistency.
“Oligonucleotide-based drugs segment held a major share of the North America oligonucleotide synthesis market in 2024”
On?????? the basis of product, the North America oligonucleotide synthesis market is divided into oligonucleotide-based drugs, synthesized oligonucleotides, reagents & consumables, and equipment. In 2024, the oligonucleotide-based drugs segment held the dominant revenue share in the North America oligonucleotide synthesis market. This reflects the high value and repeat nature of therapeutic manufacturing versus research or diagnostic oligos. Oligo drugs require GMP-grade production, high-purity, and stringent impurity control, which increases spend on synthesis, purification, and advanced QC testing. Demand is also rising for chemically modified and conjugated oligos, further lifting value per batch. In addition, as programs move from clinical to commercial, sponsors place larger and more frequent orders for validation and supply continuity.
“Therapeutic application segment is likely to exhibit a significant CAGR between 2025 and 2030”
By?????? application, the North America oligonucleotide synthesis market has been segmented into therapeutic, research, and diagnostic applications. The market was largely influenced by the therapeutic application segment in 2024. As a key reason, therapeutic programs entail the use of high-value, GMP-grade oligos, which are repeated in cycles throughout clinical trials and commercial supply. Besides, almost all therapeutic oligos require complicated chemical modifications and conjugations, which, in turn, elevate the synthesis effort and purification intensity. In addition, sponsors demand, and therefore, production must be characterized by sequence accuracy, impurity control, and lot-to-lot consistency. Hence, analytics and documentation constitute a major part of the expenditure.
“US is expected to dominate the North American oligonucleotide synthesis market between 2025 and 2030”
By country, the North America oligonucleotide synthesis market has been segregated into the US and Canada. The US market is expected to dominate the market during the forecast period. This is due to the fact that the country has the largest number of biotech/pharma programs based on RNA. As a result, GMP-grade therapeutic oligos are in high demand at various stages of development. Additionally, it has a vast infrastructure for both production and research. This allows the acceleration of scale-up and procurement.
Key companies operating in the North America oligonucleotide synthesis market include Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Biogen (US), Alnylam Pharmaceuticals, Inc. (US), Sarepta Therapeutics, Inc. (US), Agilent Technologies, Inc. (US), Maravai Life Sciences (US), Azenta US Inc. (US), and Ionis Pharmaceuticals, Inc. (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the North America Oligonucleotide Synthesis Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
